GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenetp Inc (STU:NJT) » Definitions » Cyclically Adjusted PB Ratio

Regenetp (STU:NJT) Cyclically Adjusted PB Ratio : 0.00 (As of Jun. 08, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Regenetp Cyclically Adjusted PB Ratio?

As of today (2024-06-08), Regenetp's current share price is €0.0358. Regenetp's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 was €41.23. Regenetp's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Regenetp's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:NJT's Cyclically Adjusted PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.75
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Regenetp's adjusted book value per share data for the three months ended in Mar. 2023 was €1.584. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €41.23 for the trailing ten years ended in Mar. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Regenetp Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Regenetp's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenetp Cyclically Adjusted PB Ratio Chart

Regenetp Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.31 0.25 0.08 0.09 0.01

Regenetp Quarterly Data
Apr18 Jul18 Oct18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.01 0.01 0.01 0.01

Competitive Comparison of Regenetp's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Regenetp's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenetp's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenetp's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Regenetp's Cyclically Adjusted PB Ratio falls into.



Regenetp Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Regenetp's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0358/41.23
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenetp's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, Regenetp's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book=Book Value per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=1.584/127.3478*127.3478
=1.584

Current CPI (Mar. 2023) = 127.3478.

Regenetp Quarterly Data

Book Value per Share CPI Adj_Book
201304 492.913 98.107 639.824
201307 426.324 98.557 550.865
201310 333.386 98.536 430.870
201401 265.452 98.692 342.529
201404 208.058 100.023 264.896
201407 171.274 100.520 216.985
201410 99.230 100.176 126.146
201501 84.031 98.604 108.527
201504 -19.651 99.824 -25.069
201507 -27.638 100.691 -34.955
201510 59.708 100.346 75.774
201601 -56.042 99.957 -71.399
201604 -41.519 100.947 -52.378
201607 -37.828 101.524 -47.450
201610 -38.798 101.988 -48.445
201701 -11.040 102.456 -13.722
201704 -433.287 103.167 -534.841
201707 -380.710 103.278 -469.439
201710 -358.610 104.070 -438.823
201801 -325.710 104.578 -396.628
201804 45.034 105.708 54.253
201807 92.101 106.324 110.312
201810 82.905 106.695 98.953
201903 57.571 107.251 68.359
201906 61.734 108.070 72.747
201909 44.158 108.329 51.910
201912 31.986 108.420 37.570
202003 24.546 108.902 28.704
202006 17.050 108.767 19.963
202009 13.396 109.815 15.535
202012 10.241 109.897 11.867
202103 7.410 111.754 8.444
202106 6.879 114.631 7.642
202109 7.009 115.734 7.712
202112 5.162 117.630 5.588
202203 4.066 121.301 4.269
202206 3.815 125.017 3.886
202209 2.370 125.227 2.410
202212 2.161 125.222 2.198
202303 1.584 127.348 1.584

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Regenetp  (STU:NJT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Regenetp Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Regenetp's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenetp (STU:NJT) Business Description

Industry
Traded in Other Exchanges
Address
1960 South 4250 West, Salt Lake City, UT, USA, 84104
Regenetp Inc Formerly PolarityTE Inc is a clinical-stage biotechnology company developing regenerative tissue products and biomaterials. It's focused on transforming the lives of patients by discovering, designing, and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement, or regeneration of the skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.

Regenetp (STU:NJT) Headlines

No Headlines